Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome
- 14 July 2014
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 76 (4) , 581-593
Abstract
Objective: Recently, Christianson syndrome (CS) has been determined to be caused by mutations in the X‐linked Na+/H+ exchanger 6 (NHE6). We aimed to determine the diagnostic criteria and mutational spectrum for CS.Methods: Twelve independent pedigrees (14 boys, age = 4–19 years) with mutations in NHE6 were administered standardized research assessments, and mutations were characterized.Results: The mutational spectrum was composed of 9 single nucleotide variants, 2 indels, and 1 copy number variation deletion. All mutations were protein‐truncating or splicing mutations. We identified 2 recurrent mutations (c.1498 c>t, p.R500X; and c.1710 g>a, p.W570X). Otherwise, all mutations were unique. In our study, 7 of 12 mutations (58%) were de novo, in contrast to prior literature wherein mutations were largely inherited. We also report prominent neurological, medical, and behavioral symptoms. All CS participants were nonverbal and had intellectual disability, epilepsy, and ataxia. Many had prior diagnoses of autism and/or Angelman syndrome. Other neurologic symptoms included eye movement abnormalities (79%), postnatal microcephaly (92%), and magnetic resonance imaging evidence of cerebellar atrophy (33%). Regression was noted in 50%, with recurrent presentations involving loss of words and/or the ability to walk. Medical symptoms, particularly gastrointestinal symptoms, were common. Height and body mass index measures were below normal ranges in most participants. Behavioral symptoms included hyperkinetic behavior (100%), and a majority exhibited high pain threshold.Interpretation: This is the largest cohort of independent CS pedigrees reported. We propose diagnostic criteria for CS. CS represents a novel neurogenetic disorder with general relevance to autism, intellectual disability, Angelman syndrome, epilepsy, and regression. Ann Neurol 2014;76:581–593Keywords
Funding Information
- National Institutes of Health (1-P20-GM103645-01A1)
- Burroughs Wellcome Career Award for Medical Science
- Chrisitanson Syndrome Association
- Nancy Lurie Marks Foundation for Autism Research
- Simons Foundation for Autism Research
This publication has 35 references indexed in Scilit:
- X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal–lysosomal dysfunctionBrain, 2011
- Angelman syndrome: Mutations influence features in early childhoodAmerican Journal of Medical Genetics Part A, 2010
- A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau depositionBrain, 2010
- Genetic variants in SLC9A9 are associated with measures of Attention-deficit/hyperactivity disorder symptoms in familiesPsychiatric Genetics, 2010
- Mutation in the SLC9A6 gene is not a frequent cause of sporadic Angelman-like syndromeEuropean Journal of Human Genetics, 2009
- A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardationNature Genetics, 2009
- Genome‐wide association scan of the time to onset of attention deficit hyperactivity disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associationsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Identifying Autism Loci and Genes by Tracing Recent Shared AncestryScience, 2008
- SLC9A6 Mutations Cause X-Linked Mental Retardation, Microcephaly, Epilepsy, and Ataxia, a Phenotype Mimicking Angelman SyndromeThe American Journal of Human Genetics, 2008